Sign In

Rowan Gardner

Independent Board Advisor

Rowan Gardner is a highly accomplished serial entrepreneur and angel investor with extensive experience in the life science and data analytics sectors. Here are some key details about her background and current roles:

Professional Experience

  • Currently serves as an Angel Investor at Independent, leveraging her expertise to support emerging startups and innovative ventures
  • Chief Business and Investment Officer at PrecisionLife since 202312
  • Co-founder of PrecisionLife in 201412
  • Former CEO of Ozo Innovations Ltd, focusing on enhancing efficiency and food safety in the food industry

Entrepreneurial Background

  • Founded three successful companies: Synomics, Biolauncher, and PrecisionLife
  • Involved in commercializing approximately 30 university technologies through spin-outs
  • Expertise in data analytics, bioinformatics, biotechnology, and life sciences

Skills and Specialties

  • Business planning
  • Market analysis
  • Corporate communications
  • Managing growth strategies
  • Deep understanding of capital dynamics in the startup ecosystem

Education

  • BA and MA in Biochemistry from the University of Oxford (1986-1990)12

Additional Roles

  • Independent Member at Digital Health and Care Wales1
  • Non-Executive Board Member at STFC Innovations Limited2

Rowan Gardner's career spans over 30 years in healthtech, digital health, deeptech, and biotech sectors.2 Her extensive experience and diverse skill set make her a valuable asset in the entrepreneurial and investment realms.

Highlights

Jul 1 · linkedin

Last Friday, I travelled to the Wellcome Genome Campus to disseminate PrecisionLife’s work on the #Genetics of #MECFS and #LongCovid at InvestinME Research's international conference #IIMEC16. I was presenting on behalf of my colleagues Steve Gardner, Sayoni Das and Krystyna Taylor. They were in Salt Lake City Last week with our partners at Metrodora Institute advancing our #MetroPLex clinical study in MECFS.

I was just in time to hear Dr Vicky Whittemore of the NIH presenting the recent NIH Research Roadmap report and highlighting her excitement on the potential progress in in Genetics of ME/CFS https://lnkd.in/e43-2ni2. Steve Gardner provided evidence to the Genetics Session last November – it is available on Youtube here https://lnkd.in/eMKzeuQ2

It is always daunting presenting of behalf of colleagues, and delivering my first talk on ME/CFS in the same part of the agenda as Prof Ron Davis Stanford and Dr David Systrom Harvard Medicine focused my mind.

The Campus was looking wonderful with information boards reminding me of the people I knew 30 years ago at the beginning of the HGP adventure. As I reflected on a cornucopia of translational research and clinical trials plans discussed for diseases that effect millions of people living without effective treatments. I thought the words of the late John Sulston were very apposite.

Thank you to Janet Defoe for some the images below, and the people with MECFS and Long COVID who share their data so that we can advance our understanding of these conditions and find cures.

Jun 4 · linkedin

the first thing that I saw walking into #BIO2024 today was PrecisionLife newest strategic partners' logo.

I wish all of our partners a successful convention.

Related Questions

What are some of the startups Rowan Gardner has invested in?
How did Rowan Gardner's experience at Ozo Innovations shape his investment strategy?
What are the key achievements of Rowan Gardner's companies like Synomics and Biolauncher?
How does Rowan Gardner's background in biochemistry influence his investment decisions?
What are the main sectors Rowan Gardner focuses on as an Angel Investor?
Rowan Gardner
Rowan Gardner, photo 1
Rowan Gardner, photo 2
Add to my network

Location

Greater Oxford Area